Atlas Trials

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Clinical trial NCT01403792 · COMPLETED

Trial details

NCT number
NCT01403792
Sponsor
University of Surrey
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Human Immunodeficiency Virus
Start date
2011-06-01
Primary completion
2011-11-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.